MDxHealth (MDXH) Common Equity (2020 - 2026)

MDxHealth (MDXH) has 6 years of Common Equity data on file, last reported at -$12.1 million in Q4 2025.

• Quarterly Common Equity fell 181.49% year-over-year to -$12.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.1 million (down 181.49% YoY) and the FY2025 annual result came in at -$12.1 million, down 181.49% from the prior year.
• Common Equity declined to -$12.1 million in Q4 2025 per MDXH's latest filing, from $9.0 million in the prior quarter.
• The five-year high for Common Equity was $46.9 million in Q4 2021, with the low at -$12.1 million in Q4 2025.
• Average Common Equity over 5 years is $12.5 million, with a median of $9.2 million recorded in 2022.
• Year-over-year, Common Equity surged 701.83% in 2021 and slumped 181.49% in 2025.
• MDxHealth's Common Equity stood at $46.9 million in 2021, then sank by 80.14% to $9.3 million in 2022, then decreased by 22.62% to $7.2 million in 2023, then jumped by 105.9% to $14.8 million in 2024, then tumbled by 181.49% to -$12.1 million in 2025.
• Business Quant data shows MDXH's Common Equity at -$12.1 million in Q4 2025, $9.0 million in Q2 2025, and $14.8 million in Q4 2024.